CIRS BIO CIRS CK
Home Français 한국어 日本语 中文
Medical Devices

Medical Devices

CIRS Group
Chemicals
Cosmetic
Food
Medical Devices
Agrochemicals
C&K Testing
Carbon Neutrality
Search

Technical Review Points for Registration of New Coronavirus Nucleic Acid Detection Reagents(COVID-19)

from CIRS by

On February 12th, 2020, the CMDE issued the announcement on the Release of "Technical Review Points for Registration of New Coronavirus Nucleic Acid Detection Reagents in 2019" (No. 4 of 2020).

In order to respond to the pneumonia epidemic of new coronavirus infection, in accordance with the principles of “unity of command, early intervention, immediate review, scientific approval” and the requirements to ensure product safety, effectiveness, and controllable quality, the CMDE formulated the "Technical Review Points for Registration of New Coronavirus Nucleic Acid Detection Reagents in 2019".

Technical Review Points for Registration of New Coronavirus Nucleic Acid Detection Reagents in 2019.doc

  

We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

Previous: [Case Study] The Filing of Medical Isolation Gown
Next: Detailed Explanations of Emergency Approval Procedures for Medical Device
Contact Us
+86 571 8720 6559 （GMT+8 8:30~17:00）
md@cirs-group.com
Contact Us
+86 571 8720 6559 （GMT+8 8:30~17:00）
md@cirs-group.com